DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
Status:
Terminated
Trial end date:
2010-08-22
Target enrollment:
Participant gender:
Summary
RATIONALE: Dehydroepiandrosterone (DHEA) may slow the growth of tumor cells and be an
effective treatment for women with breast cancer.
PURPOSE: This phase I trial is studying how well DHEA works in treating women undergoing
surgery for stage I, stage II, or stage III breast cancer.